(Q43599627)

English

Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Impact of prophylaxis for Mycobacterium avium complex on bacterial infections in patients with advanced human immunodeficiency virus disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Mycobacterium avium avium

1 reference

based on heuristic

inferred from title

author name string

J S Currier

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Williams

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

J Feinberg

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

S Becker

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

C Benson

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Adult Clinical Trial Group

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

language of work or name

0 references

publication date

30 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

32

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1615-1622

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11340534%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Spectrum of disease in persons with human immunodeficiency virus infection in the United States

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Trends in the incidence of outcomes defining acquired immunodeficiency syndrome (AIDS) in the Multicenter AIDS Cohort Study: 1985-1991.

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Clinical manifestations and predictors of disease progression in drug users with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Causes of death in persons with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome. AIDS Clinical Trials Group Protocol 021

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS.

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Efficacy of azithromycin in prevention of Pneumocystis carinii pneumonia: a randomised trial. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis S

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Serious Pseudomonas aeruginosa infections in patients infected with human immunodeficiency virus: a case-control study

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Pseudomonas spp. complications in patients with HIV disease: an eight-year clinical and microbiological survey

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Pseudomonas aeruginosa bacteremia in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Impaired phagocyte oxidative capacity in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Discontinuation of Primary Prophylaxis againstPneumocystis cariniiPneumonia in HIV-1–Infected Adults Treated with Combination Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection. EuroSIDA Study Group

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count. A randomized, double-blind, placebo-controlled trial. AIDS Clinical Trials Group 362 Study Team.

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Discontinuation of prophylaxis for Pneumocystis carinii pneumonia in HIV-1-infected patients treated with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F320515

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43599627&oldid=2101808976"